The results of the bioinformatic analysis were supported by the identification of IRF7 and SHC1 genes as hub IRGs, and the vitro assays demonstrated that IRF7 and SHC1 have a function in promoting tumor progression. The gene discussed is SHC1; the disease is neoplasm.